Business

"Shanghai Shyndec Pharmaceutical Co., Ltd."Announcement on the Wholly-owned Subsidiary's Drug Passing Generic Drug Consistency Evaluation

"Shanghai Shyndec Pharmaceutical Co., Ltd."Announcement on the Wholly-owned Subsidiary's Drug Passing Generic Drug Consistency Evaluation

Shanghai Shyndec Pharmaceutical Co., Ltd. Class AJuly 13, 20264
"Shanghai Shyndec Pharmaceutical Co., Ltd."Announcement on the Wholly-owned Subsidiary's Drug Passing Generic Drug Consistency Evaluation

About this update from Shanghai Shyndec Pharmaceutical Co., Ltd. Class A

Announcement on the Wholly-owned Subsidiary's Drug Passing Generic Drug Consistency EvaluationThe abstract is for reference only. Please refer to the full text of the announcement on the very day.Link of Full Text for Reference:View Attachment

View stock analysis, news, and events for Shanghai Shyndec Pharmaceutical Co., Ltd. Class A